These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25919846)

  • 1. Why patients with severe personality disorders are overmedicated.
    Paris J
    J Clin Psychiatry; 2015 Apr; 76(4):e521. PubMed ID: 25919846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and effectiveness of psychopharmacology in emotionally unstable and borderline personality disorder.
    Silk KR
    J Clin Psychiatry; 2015 Apr; 76(4):e524-5. PubMed ID: 25919848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services.
    Paton C; Crawford MJ; Bhatti SF; Patel MX; Barnes TR
    J Clin Psychiatry; 2015 Apr; 76(4):e512-8. PubMed ID: 25919844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for borderline patients: business as usual or by default?
    Ingenhoven T
    J Clin Psychiatry; 2015 Apr; 76(4):e522-3. PubMed ID: 25919847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mental health service utilization among borderline personality disorder patients inpatient].
    Cailhol L; Thalamas C; Garrido C; Birmes P; Lapeyre-Mestre M
    Encephale; 2015 Apr; 41(2):115-22. PubMed ID: 25526809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines.
    Riffer F; Farkas M; Streibl L; Kaiser E; Sprung M
    Int J Psychiatry Clin Pract; 2019 Sep; 23(3):178-188. PubMed ID: 31140337
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment utilization by patients with personality disorders.
    Bender DS; Dolan RT; Skodol AE; Sanislow CA; Dyck IR; McGlashan TH; Shea MT; Zanarini MC; Oldham JM; Gunderson JG
    Am J Psychiatry; 2001 Feb; 158(2):295-302. PubMed ID: 11156814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacologic management of patients with borderline personality disorder.
    Links PS; Steiner M
    Can J Psychiatry; 1988 Jun; 33(5):355-9. PubMed ID: 3044565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment utilization by gender in patients with borderline personality disorder.
    Goodman M; Patil U; Steffel L; Avedon J; Sasso S; Triebwasser J; Stanley B
    J Psychiatr Pract; 2010 May; 16(3):155-63. PubMed ID: 20485103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy.
    Paolini E; Mezzetti FA; Pierri F; Moretti P
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):75-79. PubMed ID: 27669762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological treatment in borderline personality disorder: A pilot observational study in a real-world setting.
    Magni LR; Ferrari C; Barlati S; Ridolfi ME; Prunetti E; Vanni G; Bateni M; Diaferia G; Macis A; Meloni S; Perna G; Occhialini G; Vita A; Rossi G; Rossi R
    Psychiatry Res; 2021 Jan; 295():113556. PubMed ID: 33189367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing an APA practice guideline: symptom-targeted medication utilization for patients with borderline personality disorder.
    Oldham JM; Bender DS; Skodol AE; Dyck IR; Sanislow CA; Yen S; Grilo CM; Shea MT; Zanarini MC; Gunderson EJ; McGlashan TH
    J Psychiatr Pract; 2004 May; 10(3):156-61. PubMed ID: 15330221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic.
    Sansone RA; Rytwinski D; Gaither GA
    Compr Psychiatry; 2003; 44(6):454-8. PubMed ID: 14610722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment for borderline personality disorder.
    Berger PA
    Bull Menninger Clin; 1987 May; 51(3):277-84. PubMed ID: 3580662
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacotherapy of borderline outpatients.
    Zanarini MC; Frankenburg FR; Gunderson JG
    Compr Psychiatry; 1988; 29(4):372-8. PubMed ID: 3409692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication utilization patterns and methods of suicidality in borderline personality disorder.
    Makela EH; Moeller KE; Fullen JE; Gunel E
    Ann Pharmacother; 2006 Jan; 40(1):49-52. PubMed ID: 16303987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacologic approaches to the borderline patient.
    Zisook S; Ricketts JE
    Hillside J Clin Psychiatry; 1988; 10(1):55-70. PubMed ID: 2900799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practices.
    Knappich M; Hörz-Sagstetter S; Schwerthöffer D; Leucht S; Rentrop M
    Int Clin Psychopharmacol; 2014 Jul; 29(4):224-8. PubMed ID: 24896541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing of psychotropic drugs to children and adolescents.
    Adams S
    BMJ; 1991 Jan; 302(6770):217. PubMed ID: 1998763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.